Latest News

Date Title Topic
27 Sep 2017 FDA Approves Lower Dose of Cabazitaxel for mCRPC Genitourinary cancers - Anticancer agents & Biologic therapy
25 Sep 2017 FDA Grants Accelerated Approval to Pembrolizumab for Advanced Gastric Cancer Gastrointestinal cancers - Cancer Immunology and Immunotherapy
25 Sep 2017 How To Overcome EGFR Mutation Resistance In Lung Cancer Lung and other thoracic tumours
25 Sep 2017 EMA Recommends Extensions of Therapeutic Indications for Nilotinib Haematologic malignancies - Cancer in Special Situations - Anticancer agents & Biologic therapy
Programme
22 Sep 2017 EMA Recommends Granting a Marketing Authorisation for Generic Imatinib Sarcomas - Haematologic malignancies - Anticancer agents & Biologic therapy
Abstracts
Programme
21 Sep 2017 Withdrawal of the Application for a Change to the Marketing Authorisation for Nivolumab in EU Cancer Immunology and Immunotherapy
20 Sep 2017 EMA Recommends Granting a Marketing Authorisation for Trastuzumab Biosimilar Breast cancer - Gastrointestinal cancers - Anticancer agents & Biologic therapy
14 Sep 2017 ESMO Press Release: ESMO announces new interim Editor-in-Chief of Annals of Oncology
19 Sep 2017 EMA Recommends Granting a Marketing Authorisation for Niraparib Gynaecologic malignancies - Anticancer agents & Biologic therapy
18 Sep 2017 FDA Approves a Biosimilar to Bevacizumab Anticancer agents & Biologic therapy
Programme
15 Sep 2017 Questionnaire Designed for Adolescent and Young Adults with Cancer Elicits Their Views on Treatment Cancer in Special Situations